Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean aprd00379 of aprd00481?
Displaying all 2 drugs
A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has...
Approved
Withdrawn
Matched Products: … BRAUN SOLUTION FOR INJECTION OR INFUSION 2 MG/ML ... ONRON 8 SOLUTION FOR INJECTION OR INFUSION 2 MG/ML ... ONRON 4 SOLUTION FOR INJECTION OR INFUSION 2 MG/ML …
Sumatriptan is a serotonin receptor agonist commonly used to treat migraines and sometimes cluster headaches.[L6793,L6796,L6799,L6805,L6808,L6811] Sumatriptan is the first of the triptans and was made available in Europe in 1991 to treat migraines. Sumatriptan was granted FDA approval on 28 December 1992.
Approved
Investigational
Displaying all 2 drugs